National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 9/17/2021 release of VAERS data:

Found 595 cases where Vaccine targets COVID-19 (COVID19) and Manufacturer is JANSSEN and Write-up contains 'thrombosis'



Case Details

This is page 2 out of 60

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11   next


VAERS ID: 1182730 (history)  
Form: Version 2.0  
Age: 30.0  
Sex: Male  
Location: Wisconsin  
Vaccinated:2021-04-07
Onset:2021-04-08
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 043A21A / 1 RA / IM

Administered by: Other       Purchased by: ?
Symptoms: Abdominal pain, Activated partial thromboplastin time shortened, Blood culture negative, Blood lactic acid normal, Chest X-ray normal, Chest pain, Chills, Differential white blood cell count normal, Dyspnoea, Electrocardiogram normal, Fibrin D dimer normal, Full blood count normal, Hyperventilation, International normalised ratio increased, Metabolic function test, N-terminal prohormone brain natriuretic peptide, Prothrombin time prolonged, Tremor, Troponin I, Urine analysis normal
SMQs:, Liver-related coagulation and bleeding disturbances (narrow), Anaphylactic reaction (broad), Acute pancreatitis (broad), Asthma/bronchospasm (broad), Haemorrhage laboratory terms (broad), Neuroleptic malignant syndrome (broad), Retroperitoneal fibrosis (broad), Parkinson-like events (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Noninfectious encephalopathy/delirium (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: acetaminophen 500 mg TID PRN pain; albuterol 90 mcg/inhalation 2 puffs QID PRN chlorhexidine topical 4% BID PRN folliculitis fluticasone-salmeterol 500 mcg-50 mcg inhalation 1 puff BID lisinopril 10 mg daily warfarin 5 mg daily warfarin 2 m
Current Illness: none
Preexisting Conditions: Factor V Leiden mutation asthma obstructive sleep apnea hypertension morbid obesity folliculitis
Allergies: soy products
Diagnostic Lab Data: 04/08/2021 at emergency room: INR 2.0, PT 21.3, PTT 31 Blood culture x 2 = negative Urinalysis normal lactic acid, comprehensive metabolic panel, CBC with differential, NT proBNP, troponin I ultra sensitive, D-dimer, - all normal chest x-ray unremarkable electrocardiogram 12-lead normal
CDC Split Type:

Write-up: 1:22 AM: chest pain, abdominal cramps, chills, difficulty breathing, hyperpnea, bilateral upper extremity trembling VS: pulse 112, respirations 22, temperature 37.0 Celsius, BP 156/103, O2 sat 99% on room air has history of deep vein thrombosis, pulmonary embolism 1:30 AM sent to emergency room via ambulance 4:00 AM report from emergency room: patient is stable and reported feeling better and breathing easier shortly after arriving to ER. Patient received 500cc NS bolus IV. Labs findings unremarkable. INR 2.0, PT 21.3, PTT 31. Last taken VS -BP 127/71, P109, R20, O2 93%RA. Patient will be discharging with Dx: reaction to COVID vaccine.


VAERS ID: 1191213 (history)  
Form: Version 2.0  
Age: 49.0  
Sex: Male  
Location: Pennsylvania  
Vaccinated:2021-04-08
Onset:2021-04-08
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: Deep vein thrombosis, Hypersensitivity
SMQs:, Angioedema (broad), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Depression
Allergies: Bee Stings
Diagnostic Lab Data:
CDC Split Type:

Write-up: systemic reaction followed by deep vein thrombosis


VAERS ID: 1197638 (history)  
Form: Version 2.0  
Age: 38.0  
Sex: Female  
Location: Colorado  
Vaccinated:2021-03-13
Onset:2021-03-19
   Days after vaccination:6
Submitted: 0000-00-00
Entered: 2021-04-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / 1 - / IM

Administered by: Public       Purchased by: ?
Symptoms: Abdominal pain, Blood fibrinogen decreased, Blood lactic acid, Disseminated intravascular coagulation, Fibrin D dimer, Intensive care, Laparotomy, Mesenteric artery thrombosis, Platelet count decreased, Small intestinal resection, Small intestine gangrene, Thrombocytopenia
SMQs:, Liver-related coagulation and bleeding disturbances (narrow), Acute pancreatitis (broad), Haematopoietic thrombocytopenia (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhage laboratory terms (broad), Systemic lupus erythematosus (broad), Retroperitoneal fibrosis (broad), Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Malignancy related therapeutic and diagnostic procedures (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Ischaemic colitis (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 23 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: none
Current Illness: morbid obesity, alcohol use.
Preexisting Conditions: morbid obesity
Allergies: nkda
Diagnostic Lab Data: Platelets 20000 on 3/20/21. Lactate 13.9 on 3/20/21. fibrinogen 127 on 3/20/21. D-Dimer 10.10 on 3/20/21.
CDC Split Type:

Write-up: Patient presented with acute abdominal pain, DIC , thrombocytopenia and found have small bowel gangrene due to SMA thrombosis. Underwent Laparotomy with small bowel resection. Was in the ICU and currently on TPN and IV antibiotics.


VAERS ID: 1198162 (history)  
Form: Version 2.0  
Age: 45.0  
Sex: Female  
Location: Missouri  
Vaccinated:2021-03-13
Onset:2021-03-20
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-04-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / 1 - / -

Administered by: Pharmacy       Purchased by: ?
Symptoms: Brain death, Cerebral venous sinus thrombosis, Death, Dizziness, Headache, Vomiting
SMQs:, Acute pancreatitis (broad), Anticholinergic syndrome (broad), Embolic and thrombotic events, venous (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Central nervous system vascular disorders, not specified as haemorrhagic or ischaemic (narrow), Vestibular disorders (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-27
   Days after onset: 7
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: My sister received the Janssen vaccine on March 13, 2021. One week later, March 20, 2021, she started complaining of severe headaches, dizziness and vomiting. This continued so she visited the ER on Wednesday, March 24, 2021, where she suffered a cerebral venous sinus thrombosis. She was pronounced brain dead on March 27, 2021, which is also the same day she was pronounced dead.


VAERS ID: 1200992 (history)  
Form: Version 2.0  
Age: 39.0  
Sex: Male  
Location: D.C.  
Vaccinated:2021-03-13
Onset:2021-03-29
   Days after vaccination:16
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805018 / N/A LA / SYR

Administered by: Public       Purchased by: ?
Symptoms: Deep vein thrombosis, Pain in extremity, Thrombosis, Ultrasound Doppler abnormal
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Cardiomyopathy (broad), Tendinopathies and ligament disorders (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Amphetamine salts, 30mg, daily Zoloft, 25mg a day Wellbutrin, 50mg/day
Current Illness:
Preexisting Conditions: I had DVT in 2009
Allergies:
Diagnostic Lab Data: 4/07/21: 1:01pm: Imaging: VL Venous doppler lower extremity right. Findings: 1) "Findings consistent with superficial veinous thrombosis of the great samphenous vein brlow the knee and lesser saphenous vein." 2) "Finding consistent with acute occlusive deep veinous thrombosis of the gastrocnemius veins."
CDC Split Type:

Write-up: I developed leg pain in my right leg 2 weeks after vaccination. A week later, I went to the hospital and they confirmed "Acute deep vein thrombosis) DVT of calf muscle vein of right lower extremity" and at least one additional superficial clot. I was prescribed blood thinners apixaban (Eliquis) and was discharged. I''d previously had a clot in the same leg in 2009.


VAERS ID: 1201055 (history)  
Form: Version 2.0  
Age: 83.0  
Sex: Female  
Location: New Jersey  
Vaccinated:2021-03-19
Onset:2021-04-07
   Days after vaccination:19
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805029 / 1 LA / SYR

Administered by: Private       Purchased by: ?
Symptoms: Dyspnoea, Intensive care, Laboratory test, Pulmonary embolism
SMQs:, Anaphylactic reaction (broad), Embolic and thrombotic events, venous (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: none
Preexisting Conditions: none
Allergies: none
Diagnostic Lab Data: I stayed in the ICU for several days - they took many tests. 4/7 - 4/10
CDC Split Type:

Write-up: Shortness of breath and rushed to ER - they found massive blood clot in both lobes of my lungs. No sign of Deep Vein Thrombosis - seems a mystery. Almost fatal if not gotten to ER so quickly they said. I was in the ICU from 4/7 - 4/10


VAERS ID: 1201612 (history)  
Form: Version 2.0  
Age: 58.0  
Sex: Female  
Location: Nevada  
Vaccinated:2021-03-23
Onset:2021-03-23
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805025 / 1 LA / SYR

Administered by: Private       Purchased by: ?
Symptoms: Chest discomfort, Headache, Pain, Pain in extremity
SMQs:, Anaphylactic reaction (broad), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Triamterene 1/2 of 85 mg, Telmisarten 20mg, baby aspirin, hair and nail vitamins, 400 IU Vitamin D, 400mg Magnesium and Potassium.
Current Illness: I have borderline NONimmune system controlled Lupus, but again I do not take medication to control it.
Preexisting Conditions: Hypertension, stroke survivor and I have a hole in my heart (PFO).
Allergies: Penicillin and Gadolinium
Diagnostic Lab Data: None
CDC Split Type:

Write-up: On 23 March 2021 I received the Janssen Covid-19 Vaccine LOT #1805025. I contacted Johnson & Johnson via phone to report that I was experiencing an intense, deep pain in my upper left thigh and a headache about two hours after receiving the Janssen vaccine. Case #ICSR Information : 20210346108 JANSSEN COVID-19 VACCINE SECURE! The pain in my thigh worsened whenever I stood or sat still. I inquired if thrombosis is a side effect or something that I need to be concerned about. The woman on the phone said she looked up thrombosis, but did not see it listed. I asked if I should start taking aspirin. The woman on the phone said that she could not give me medical advice. I was so concerned that I took a full aspirin about every four hours for twelve hours on that day and a full aspirin for about three days thereafter and two baby aspirin ever since. The pain in my thigh diminished by 26 March 2021, but ended a few days later. The headache occurred intermittently. I have had some chest discomfort since then, but it hasn''t risen to the level of angina. I am still concerned about thrombosis because of the intensity of the pain.


VAERS ID: 1201967 (history)  
Form: Version 2.0  
Age: 36.0  
Sex: Female  
Location: Texas  
Vaccinated:2021-03-25
Onset:2021-04-09
   Days after vaccination:15
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1808609 / 1 RA / IM

Administered by: Public       Purchased by: ?
Symptoms: Cerebral venous sinus thrombosis, Headache, Intensive care, International normalised ratio increased, Magnetic resonance imaging head abnormal, Platelet count decreased, Prothrombin time prolonged, Scan with contrast abnormal, Superior sagittal sinus thrombosis, Transverse sinus thrombosis, Venogram abnormal, Vomiting
SMQs:, Liver-related coagulation and bleeding disturbances (narrow), Acute pancreatitis (broad), Haematopoietic thrombocytopenia (narrow), Haemorrhage laboratory terms (broad), Systemic lupus erythematosus (broad), Embolic and thrombotic events, venous (narrow), Malignancy related therapeutic and diagnostic procedures (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Central nervous system vascular disorders, not specified as haemorrhagic or ischaemic (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: No prescriptions, OTC, dietary supplements o herbal remedies
Current Illness: None
Preexisting Conditions: None
Allergies: NKDA
Diagnostic Lab Data: (1) 4/12/21, MRI venogram sagital sinus wo contrast: "Findings suggest thrombosis of the superior sagittal sinus and transverse sinuses and straight sinus. There is no significant flow in the sigmoid sinuses and jugular vein may be related to decreased flow and/or thrombosis as well." (2) 4/12/21, MRI Brain w wo contrast: "Findings suggesting a diffuse transverse and sigmoid sinus thrombosis. Poor of flow void visualization of the jugular veins as well and is possible these could be occluded as well. No prominent hematoma is detected but on the gradient echo sequences there is prominent diminished signal in the sulci bilaterally and this can be seen in minor of subarachnoid hemorrhage. No midline shifting or mass effect is detected." (3) 4/12/21, Protime=15.4 sec (4) 4/12/21, INR=1.2 (5) 4/12/12, PLT= 64 k/uL
CDC Split Type:

Write-up: 36 y.o. female referred for the above chief complaint. She has no significant medical history and presented with a headache that became severe 3 days ago. She received the Johnson and Johnson COVID vaccine on March 25th and had a mild headache following that which she attributed to the vaccine. 3 days ago the pain became excruciating and was associated with vomiting. This prompted presentation to the ED where she was treated with Dilaudid. She was discharged home and has been using her mom''s headache cocktail with some transient relief. She presented back to the ED today with continued symptoms. MRV revealed a venous sinus thrombosis and neurology was therefore consulted. She has no history of clots personally or in the family. Her dad did have a stroke in his 50s. Patient otherwise denies any other associated speech change, vision change, extremity numbness, extremity weakness, coordination difficulty, or dizziness. Patient admitted to the neurology ICU and started on anticoagulation.


VAERS ID: 1203128 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Florida  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Deep vein thrombosis, Factor V Leiden mutation, Platelet count, Pulmonary embolism, Renal haemorrhage, SARS-CoV-2 test
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Congenital, familial and genetic disorders (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: Unknown
Allergies:
Diagnostic Lab Data: Test Date: 2021; Test Name: Factor V Leiden mutation; Result Unstructured Data: positive for one copy; Test Date: 2021; Test Name: COVID-19 virus test; Result Unstructured Data: negative; Test Date: 2021; Test Name: Platelet count; Result Unstructured Data: 264000; Test Date: 2021; Test Name: Platelet count; Result Unstructured Data: 191000
CDC Split Type: USJNJFOC20210421548

Write-up: DVT; PULMONARY EMBOLISM; KIDNEY BLEEDING; This spontaneous report was received from a physician, and concerned an adult male patient (greater than 50 years old). Initial report was processed along with additional information received on 12-APR-2021. The patient''s weight, height, and medical history were not reported. The patient received Covid-19 vaccine AD26.Cov2.S (suspension for injection, intramuscular, batch number was not reported) dose and site of vaccination were not reported, administered on 20-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date in 2021, the patient experienced deep vein thrombosis (DVT), pulmonary embolism (PE), and kidney bleeding. The patient was admitted to the hospital and was treated with heparin as well as an inferior vena cava (IVC) filter (put in after he experienced bleeding from his kidney). Laboratory data included: a negative COVID-19 virus test, and throughout hospitalization his platelet count (NR: not provided) was normal: 191,000 and 264,000 (units not provided). The patient''s test came back positive for one copy of the Factor V Leiden mutation which predisposed him to blood clots. On 12-APR-2021, the patient was to start a trial to Lovenox (enoxaparin sodium); they will assure there is no bleeding, prior to discharge. At the time of this report, the patient was still hospitalized but doing well. Action taken with Covid-19 vaccine AD26.Cov2.S was not applicable. The patient was recovering from DVT, pulmonary embolism, and kidney bleeding. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender''s Comments: v0 An adult (greater than 50 years old) male patient with a past medical history remarkable for the Factor V Leiden mutation experienced deep vein thrombosis, pulmonary embolism, and kidney bleeding on an unspecified date after receiving Janssen COVID-19 Vaccine Ad26.COV2.S. The patient was admitted to the hospital and was treated with heparin as well as an inferior vena cava (IVC) filter (put in after he experienced bleeding from his kidney). The patient had a negative COVID-19 virus test, and throughout hospitalization his platelet count was normal: 191,000 and 264,000 (units not provided). The Factor V Leiden mutation is known to predispose patients to venous thrombosis, therefore the causality for deep vein thrombosis, pulmonary embolism as well a consequent kidney bleeding most likely due to heparin treatment is assessed not related to the vaccination.


VAERS ID: 1204240 (history)  
Form: Version 2.0  
Age: 62.0  
Sex: Male  
Location: Virginia  
Vaccinated:2021-04-11
Onset:2021-04-13
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Thrombophlebitis superficial, Ultrasound scan abnormal
SMQs:, Embolic and thrombotic events, venous (narrow), Malignancy related therapeutic and diagnostic procedures (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: NOne
Current Illness: None
Preexisting Conditions: None
Allergies: NKA
Diagnostic Lab Data: As above, Confirmed with Ultrasound.
CDC Split Type:

Write-up: Left Leg Superficial Thrombosis.


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=2&WRITEUP=thrombosis&VAX=COVID19&VAXTYPES=COVID-19&VAXMAN=JANSSEN


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166